Antal Rohit Desai - 05 Mar 2026 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director
Signature
/s/ Antal Rohit Desai
Issuer symbol
PRCT
Transactions as of
05 Mar 2026
Net transactions value
+$10,482,943
Form type
4
Filing time
09 Mar 2026, 19:19:42 UTC
Previous filing
15 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Desai Antal Rohit Director C/O PROCEPT BIOROBOTICS CORPORATION, 150 BAYTECH DRIVE, SAN JOSE /s/ Antal Rohit Desai 09 Mar 2026 0001881616

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Purchase $3,625,021 +142,498 $25.44 142,498 05 Mar 2026 Kestrel Fund, L.P. F1, F2
transaction PRCT Common Stock Purchase $653,528 +24,748 +17% $26.41 167,246 05 Mar 2026 Kestrel Fund, L.P. F2, F3
transaction PRCT Common Stock Purchase $2,485,713 +106,554 +64% $23.33 273,800 06 Mar 2026 Kestrel Fund, L.P. F2, F4
transaction PRCT Common Stock Purchase $1,295,790 +53,763 +20% $24.10 327,563 06 Mar 2026 Kestrel Fund, L.P. F2, F5
transaction PRCT Common Stock Purchase $1,049,500 +43,581 +13% $24.08 371,144 09 Mar 2026 Kestrel Fund, L.P. F2, F6
transaction PRCT Common Stock Purchase $1,340,348 +53,818 +15% $24.91 424,962 09 Mar 2026 Kestrel Fund, L.P. F2, F7
transaction PRCT Common Stock Purchase $33,042 +1,300 +0.31% $25.42 426,262 09 Mar 2026 Kestrel Fund, L.P. F2, F8
holding PRCT Common Stock 35,152 05 Mar 2026 Direct
holding PRCT Common Stock 14,363 05 Mar 2026 By The 2:22 DNA Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.0645 to $26.0213, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2 CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.10 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.785 to $23.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.79 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.40 to $24.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F7 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.40 to $25.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F8 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.40 to $25.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.